These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours. Trerè D, Ceccarelli C, Danova M, Derenzini M. Eur J Histochem; 1996; 40(1):17-26. PubMed ID: 8741096 [Abstract] [Full Text] [Related]
4. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma. Eminović-Behrem S, Trobonjaca Z, Petrovecki M, Dobi-Babić R, Dujmović M, Jonjić N. Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043 [Abstract] [Full Text] [Related]
6. [Prognostic value of AgNORs in breast cancer]. Aubele M, Auer G, Jütting U. Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674 [Abstract] [Full Text] [Related]
7. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions. Carrillo R, Sneige N, el-Naggar AK. Acta Cytol; 1994 Mar; 38(3):367-72. PubMed ID: 8191825 [Abstract] [Full Text] [Related]
11. Ploidy and kinetics: comparative study with DNA flow cytometry and AgNOR protein quantification with image analysis. Grigolato PG, Tebaldi P, Cadei M, Alpi F, Lucchini K. Eur J Histochem; 1997 Mar; 41 Suppl 2():131-2. PubMed ID: 9859816 [No Abstract] [Full Text] [Related]
12. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes? Giuffrè G, Barresi G, Speciale G, Sarnelli R, Gioffrè Florio MA, Tuccari G. Eur J Histochem; 1997 Mar; 41(2):111-8. PubMed ID: 9271703 [Abstract] [Full Text] [Related]
13. Nucleolar organiser regions (AgNORs) related to histopathological characteristics and survival in prostatic adenocarcinoma. Eskelinen M, Lipponen P, Syrjänen K. Anticancer Res; 1992 Mar; 12(5):1635-40. PubMed ID: 1444230 [Abstract] [Full Text] [Related]
14. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool. Giuffrè G, Mormandi F, Barresi V, Bordi C, Tuccari G, Barresi G. Eur J Histochem; 2006 Mar; 50(1):45-50. PubMed ID: 16584984 [Abstract] [Full Text] [Related]
15. [Significance of the AgNOR in tumor pathology]. Pich A, Margaria E, Chiusa L. Pathologica; 2002 Feb; 94(1):2-9. PubMed ID: 11912874 [Abstract] [Full Text] [Related]
16. Measurement of DNA ploidy and proliferation rate in lung tumours by bromodeoxyuridine labelling index, S-phase fraction and AgNOR technique. Gasińska A, Biesaga B, Kołodziejski L, Słonina D. Pol J Pathol; 1996 Feb; 47(4):201-7. PubMed ID: 9097713 [Abstract] [Full Text] [Related]
17. Nucleolar organizer regions: a potential prognostic factor in adenocarcinoma of the endometrium. Miller B, Morris M, Silva E. Gynecol Oncol; 1994 Aug; 54(2):137-41. PubMed ID: 8063236 [Abstract] [Full Text] [Related]
18. Digital image analysis of silver-stained nucleolar organizer region--associated proteins in endometrial cytologic samples. Mahovlić V, Audy-Jurković S, Ovanin-Rakić A, Bilusić M, Veldić M, Babić D, Bozikov J, Danilović Z. Anal Quant Cytol Histol; 1999 Feb; 21(1):47-53. PubMed ID: 10068775 [Abstract] [Full Text] [Related]
19. A prognostic model of survival in surgically resected squamous cell carcinoma of the lung using clinical, pathologic, and biologic markers. Bernardi FD, Antonângelo L, Beyruti R, Takagaki T, Saldiva PH, Capelozzi VL. Mod Pathol; 1997 Oct; 10(10):992-1000. PubMed ID: 9346178 [Abstract] [Full Text] [Related]
20. [Silver-stained Nucleolar Organizer Regions (AgNOR)]. Derenzini M, Trerè D. Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299 [Abstract] [Full Text] [Related] Page: [Next] [New Search]